verified SJR 1,063 · Q1 • database Scopus / SJR & Web of Science indexed

Germany · Springer Verlag

workspace_premium Q1 — Economics, Econometrics and Finance (miscellaneous) lock Subscription

European Journal of Health Economics

European Journal of Health Economics is a journal indexed in SJR in Economics, Econometrics and Finance (miscellaneous) and Health Policy with an H index of 71. It has a price of 2990 €. It has an SJR impact factor of 1,063 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,063.

European Journal of Health Economics focuses its scope in these topics and keywords: treatment, health, state, model, strategies, effects, costs, colorectal, changing, cancer, ...

ISSN: 1618-7598

Publisher: Springer Verlag

Category: Economics, Econometrics and Finance (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,063 Q1

H-index 71

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.990 € Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,063

H-index

Docs (year)

159

Docs 3y

342

Total refs

7873

Cites 3y

1212

Citable 3y

309

Cites/Doc 2y

3.29

Ref/Doc

49.52

Immediate OA

2990 €

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Burden of illness imposed by severe sepsis in Germany

What criteria for pharmaceuticals reimbursement?

Costs and effectiveness of a syringe distribution and needle exchange program for HIV prevention in a regional setting

Cost-utility of interferon beta 1b in the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosis

Cost-effectiveness of hepatitis A immunization of children and adolescents in Germany

Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden

Cost-effectiveness analysis of two strategies for typing unrelated donors for bone marrow transplantation in France

Corruption costs lives: evidence from a cross-country study

Competition in pharmaceuticals: more product- than price-oriented?

Comparison of general practitioner records and patient self-report questionnaires for estimation of costs

Comparison of estimated medical costs among patients who are defined as having rheumatoid arthritis using three different standards

Changes in cost-effectiveness over time

SHOW MORE ARTICLES

Chained time trade-off and standard gamble methods

"Commentary on Coyle et al., ""The assessment of the economic return from controlled clinical trials"

Betreute Wohnformen fur chronisch schizophren Erkrankte

Approval times and the safety of new pharmaceuticals

An exponential representation of health state utility

Adapting portfolio theory for the evaluation of multiple investments in health with a multiplicative extension for treatment synergies

A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor

A Markov model of treatment of newly diagnosed epilepsy in the UK

A fuzzy logic approach toward solving the analytic enigma of health system financing

A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK

A comparison of the EuroQol and the Health Utilities Index in patients treated for congenital anomalies

FAQs

European Journal of Health Economics has an SJR of 1,063 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2990 EUR.

The acceptance rate recorded for European Journal of Health Economics is 29%.

European Journal of Health Economics

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of European Journal of Health Economics?

What is the APC / publication cost?

What is the acceptance rate?